[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Chagas Disease (American Trypanosomiasis) Ongoing Global Clinical Trials Analysis and Outlook

June 2018 | 34 pages | ID: CCFD6D65071EN
VPAResearch

US$ 700.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Chagas Disease (American Trypanosomiasis) ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Chagas Disease (American Trypanosomiasis) disease clinical trials. The research work analyzes the ongoing Chagas Disease (American Trypanosomiasis) clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Chagas Disease (American Trypanosomiasis) treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Chagas Disease (American Trypanosomiasis) clinical trials.

Scope of the Report-
  • Ongoing Chagas Disease (American Trypanosomiasis) clinical trials across regions
  • Trial information by Phase and Subjects recruited
  • Trial information by status, type, sponsor type
  • Drugs used for treatment of Chagas Disease (American Trypanosomiasis)
  • Both observational and interventional trials analyzed
  • Leading companies and universities participating in Chagas Disease (American Trypanosomiasis) clinical trials
Reasons to Buy
  • Track competition and design competitive advantages
  • Identify right partners to associate with for further research
  • Evaluate potential opportunities available in further clinical trials of the disease
  • Formulate business development strategies through success rates of clinical trials
  • Identify quick markets for recruiting subjects based on trials count by each market
1 TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2 KEY FINDINGS, 2018

2.1 Snapshot
2.2 Overview of Chagas Disease (American Trypanosomiasis) Trials

3 CLINICAL TRIALS TRENDS TO 2022

3.1 Ongoing Chagas Disease (American Trypanosomiasis) Trials by Phase
3.2 Ongoing Chagas Disease (American Trypanosomiasis) Trials by Type
3.3 Ongoing Chagas Disease (American Trypanosomiasis) Trials by Recruitment Status

4 COUNTRY LEVEL ANALYSIS

4.1 Region wise Ongoing Chagas Disease (American Trypanosomiasis) Trials
4.2 Top 10 Countries conducting Chagas Disease (American Trypanosomiasis) Trials
4.3 Trials in Emerging and Developing Economies

5 COMPANY LEVEL ANALYSIS

5.1 Ongoing Chagas Disease (American Trypanosomiasis) Trials by Sponsor Type
5.2 Chagas Disease (American Trypanosomiasis) Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 ENROLMENT TRENDS TO 2022

6.1 Subjects Recruited for Chagas Disease (American Trypanosomiasis) Trials by year
6.2 Subjects Recruited for Chagas Disease (American Trypanosomiasis) Trials by Phase
6.3 Subjects Recruited for Chagas Disease (American Trypanosomiasis) Trials by Trial Type
6.4 Subjects Recruited for Chagas Disease (American Trypanosomiasis) Trials by Recruitment Status

7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS

7.1 Ongoing Chagas Disease (American Trypanosomiasis) Trials- Phase
7.2 Ongoing Chagas Disease (American Trypanosomiasis) Trials- Phase
7.3 Ongoing Chagas Disease (American Trypanosomiasis) Trials- Phase
7.4 Ongoing Chagas Disease (American Trypanosomiasis) Trials- Phase

8 APPENDIX

8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

LIST OF FIGURES

Figure 1: Chagas Disease (American Trypanosomiasis)- Clinical Trials by Country
Figure 2: Chagas Disease (American Trypanosomiasis)- Clinical Trials by Phase of Development, 2018
Figure 3: Chagas Disease (American Trypanosomiasis)- Clinical Trials by Status, 2018
Figure 4: Chagas Disease (American Trypanosomiasis)- Clinical Trials by Type, 2018
Figure 5: Chagas Disease (American Trypanosomiasis)- Clinical Trials Split by Region, 2000-2018
Figure 6: Chagas Disease (American Trypanosomiasis)- Clinical Trials by Type of Economy, 2018
Figure 7: Chagas Disease (American Trypanosomiasis)- Enrolment by Phase, 2018
Figure 8: Chagas Disease (American Trypanosomiasis)- Enrolment by Trial Type, 2018
Figure 9: Chagas Disease (American Trypanosomiasis)- Enrolment by Recruitment Status, 2018
Figure 10: Chagas Disease (American Trypanosomiasis)- Clinical Trials by Sponsor Type, 2018
Figure 11: Chagas Disease (American Trypanosomiasis)- Enrolment by Type of Sponsors
Figure 12: Chagas Disease (American Trypanosomiasis)- Enrolment by Leading Sponsors

LIST OF TABLES

Table 1: Chagas Disease (American Trypanosomiasis)- Clinical Trials by Sponsor Type, 2018
Table 2: Chagas Disease (American Trypanosomiasis)- Clinical Trials by Economy Type, 2018
Table 3: Chagas Disease (American Trypanosomiasis)- Clinical Trials by Region, 2018
Table 4: Chagas Disease (American Trypanosomiasis)- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Chagas Disease (American Trypanosomiasis)- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Chagas Disease (American Trypanosomiasis)- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Chagas Disease (American Trypanosomiasis)- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Chagas Disease (American Trypanosomiasis)- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Chagas Disease (American Trypanosomiasis)- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company


More Publications